#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Ifinatamab deruxtecan in Patients With Advanced Esophageal Squamous Cell Carcinoma

    Recruiting

    1 1
    Investigated drugs:
    Czechia France Germany Norway

  • A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia Denmark Finland France Germany +4

  • Study of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Denmark France Germany Italy The Netherlands +5

  • Study on Tislelizumab for Elderly Patients with Advanced Esophageal Squamous Cell Carcinoma Unfit for Chemotherapy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Czechia France Germany Italy Norway

  • Study of Lenvatinib, Pembrolizumab, and Chemotherapy Combination for Patients with Advanced Esophageal Cancer Previously Treated with PD-1/PD-L1 Therapy

    Recruiting

    1 1 1
    Investigated drugs:
    Germany Italy Norway

  • Study Comparing Chemoradiotherapy with Fluorouracil, Cisplatin, and Carboplatin for Patients with Operable Esophageal Squamous Cell Carcinoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Ireland Norway Sweden

  • Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Atezolizumab and Tiragolumab for Patients with Unresectable Esophageal Squamous Cell Carcinoma After Chemoradiotherapy

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium France Germany Greece Italy +3

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France